Invention Grant
- Patent Title: Bacterial host strain expressing recombinant DSBC
-
Application No.: US15667649Application Date: 2017-08-03
-
Publication No.: US09957328B2Publication Date: 2018-05-01
- Inventor: Mark Ellis , David Paul Humphreys
- Applicant: UCB PHARMA, S.A.
- Applicant Address: GB Slough, Berkshire
- Assignee: UCB PHARMA, S.A.
- Current Assignee: UCB PHARMA, S.A.
- Current Assignee Address: GB Slough, Berkshire
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP11173880 20110713
- Main IPC: C12N1/20
- IPC: C12N1/20 ; C07K16/28 ; C12N9/90
Abstract:
The present invention provides a recombinant gram-negative bacterial cell comprising an expression vector comprising a recombinant polynucleotide encoding DsbC and one or more polynucleotides encoding an antibody or an antigen-binding fragment thereof specifically binding to CD154.
Public/Granted literature
- US20170335003A1 BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DSBC Public/Granted day:2017-11-23
Information query
IPC分类:
